Salarius Pharmaceuticals Reports Business Highlights with Fourth Quarter and Full-Year 2020 Financial Results Back Salarius Pharmaceuticals Reports Business Highlights with Fourth Quarter and Full-Year 2020 Financial Results Read More
Salarius Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results Back Salarius Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results Read More
Salarius Announces Closing of $23 Million Underwritten Public Offering of Common Stock Following Full Exercise of Over-Allotment Option Back Salarius Announces Closing of $23 Million Underwritten Public Offering of Common Stock Following Full Exercise of Over-Allotment Option Read More
Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Back Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Read More
Salarius Announces Proposed Public Offering of Common Stock Back Salarius Announces Proposed Public Offering of Common Stock Read More